The effect of sunitinib on biomarkers and tumor heterogeneity in metastatic clear cell renal cancer.

被引：0
|
作者：
Stewart, Grant
Laird, Alexander
O'Mahony, Fiach
Eory, Lel
Lubbock, Alexander
Nanda, Jyoti
O'Donnell, Marie
Mackay, Alan
Mullen, Peter
McNeill, Alan
Riddick, Antony
Aitchison, Michael
Berney, Daniel
Bex, Axel
Overton, Ian
Harrison, David James
Powles, Tom
机构：
[1] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[2] Roslin Inst, Edinburgh, Midlothian, Scotland
[3] MRC Human Genet Unit, Edinburgh, Midlothian, Scotland
[4] Royal Marsden NHS Fdn Trust, Inst Canc Res, London, England
[5] Univ St Andrews, St Andrews, Fife, Scotland
[6] Addenbrookes Hosp, Dept Urol, Cambridge CB2 2QQ, England
[7] Gartnavel Royal Hosp, Glasgow, Lanark, Scotland
[8] St Bartholomews Hosp, London, England
[9] Netherlands Canc Inst, Amsterdam, Netherlands
[10] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland
[11] Queen Mary Univ London, Barts Canc Inst, Barts Expt Canc Med Ctr, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.408
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
408
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The Effect of Sunitinib on Immune Subsets in Metastatic Clear Cell Renal Cancer
    Powles, Thomas
    Chowdhury, Simon
    Bower, Mark
    Saunders, Nataile
    Lim, Louise
    Shamash, Jonathan
    Sarwar, Naveed
    Sadev, Anju
    Peters, John
    Green, James
    Boleti, Katia
    Augwal, Samir
    UROLOGIA INTERNATIONALIS, 2011, 86 (01) : 53 - 59
  • [2] Looking for predictive biomarkers for sunitinib in metastatic renal clear cell carcinoma (mRCC)
    Maroto, P.
    Esteban, E.
    Méndez-Vidal, M. J.
    Fernandez-Parra, E. M.
    Leon, L.
    Perez-Valderrama, B.
    Domenech, M.
    Calderero, V.
    Perez-Gracia, J. L.
    Algaba, F.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S676 - S676
  • [3] Effect of sunitinib treatment on mutations and methylation in metastatic renal cancer.
    Stewart, Grant
    Van Neste, Christophe
    Meynert, Alison
    Semple, Colin
    O'Mahony, Finch
    Laird, Alexander
    Mackay, Alan
    Trooskens, Geert
    Van Criekinge, Wim
    De Meyer, Tim
    Powles, Thomas
    Harrison, David James
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [4] An indirect comparison of the toxicity of sunitinib and pazopanib in metastatic clear cell renal cancer
    Powles, Thomas
    Sarwar, Naveed
    Jones, Rob
    Wilson, Peter
    Boleti, Ekaterini
    Protheroe, Andrew
    Crabb, Simon J.
    Shamash, Jonathan
    Stockdale, Andrew
    Rashid, Sukaina
    Nathan, Paul
    Chowdury, Simon
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (17) : 3171 - 3176
  • [5] PRESURGICAL SUNITINIB IN METASTATIC CLEAR CELL RENAL CANCER (MRCC): SURGICAL SAFETY AND EFFECT ON THE PRIMARY TUMOUR
    Powles, T.
    Peters, J.
    Horenblas, S.
    Meinhardt, W.
    O'Brein, T.
    Sahdev, A.
    Lim, L.
    Green, J.
    Chowdhury, S.
    Nargund, V.
    Bycroft, J.
    Hannen, J.
    Bex, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 64 - 65
  • [6] Biomarkers to predict response to sunitinib therapy and prognosis in metastatic renal cell cancer
    Yuasa, Takeshi
    Takahashi, Shunji
    Hatake, Kiyohiko
    Yonese, Junji
    Fukui, Iwao
    CANCER SCIENCE, 2011, 102 (11) : 1949 - 1957
  • [7] Anti-tumor and anti-metastatic effect of sunitinib in a patient derived metastatic clear cell renal cell carcinoma xenograft model
    Adelaiye-Ogala, Remi M.
    Shen, Li
    Chintala, Sreenivasulu
    Ciamporcero, Eric
    Orillion, Ashley
    Elbanna, May
    Ku, Shengyu
    Miles, Kiersten Marie
    Gillard, Bryan
    Buck, Michael
    Pili, Roberto
    CANCER RESEARCH, 2015, 75
  • [8] Dynamic epigenetic changes to VHL occur with sunitinib in metastatic clear cell renal cancer
    Stewart, Grant D.
    Powles, Thomas
    Van Neste, Christophe
    Meynert, Alison
    O'Mahony, Fiach
    Laird, Alexander
    Deforce, Dieter
    Van Nieuwerburgh, Filip
    Trooskens, Geert
    Van Criekinge, Wim
    De Meyer, Tim
    Harrison, David J.
    ONCOTARGET, 2016, 7 (18) : 25241 - 25250
  • [9] The safety and efficacy of sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer
    Powles, T.
    Kayani, I.
    Blank, C. U.
    Chowdhury, S.
    Horenblas, S.
    Sarwar, N.
    Nathan, P. D.
    Boleti, E.
    Haanen, J. B.
    Bex, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer
    Powles, T.
    Kayani, I.
    Blank, C.
    Chowdhury, S.
    Horenblas, S.
    Peters, J.
    Shamash, J.
    Sarwar, N.
    Boletti, K.
    Sadev, A.
    O'Brien, T.
    Berney, D.
    Beltran, L.
    Haanen, J.
    Bex, A.
    ANNALS OF ONCOLOGY, 2011, 22 (05) : 1041 - 1047
12345